Chronic lymphocytic leukaemia refractory

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
BCL-2 inhibitor 1 substance
Phase III: 1 Phase I: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting Academic
    VENETOCLAX
    2025-524283-38-00 1 country n=456
    Pending

Phase I

1 trial
  • Ubix Therapeutics Inc. Commercial
    IMP not specified
    2023-510484-35-00 1 country n=42
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Ubix Therapeutics Inc. Commercial 1 Phase I 0
Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting Academic 1 Phase III 0
← All indication landscapes